ACE2 and COVID-19: Especially, since, very recently in different articles, it was shown that not only is EBV DNA increased in COVID-19 patients, but EBV reactivation and lytic replication induces ACE2 expression and enhances SARS-CoV-2 entry into the epithelial cell (53–55).